Longboard Pharmaceuticals Inc reports results for the quarter ended in June - Earnings Summary

Longboard Pharmaceuticals

09/08/2021 14:40

* Longboard Pharmaceuticals Inc  LBPH.OQ  reported a quarterly
adjusted loss of 41 cents​​ per share for the quarter ended in
June. The mean expectation of three analysts for the quarter was
for a loss of 67 cents per share.
* Reported revenue was zero​;  analysts expected zero. 
* Longboard Pharmaceuticals Inc's reported EPS for the quarter
was a loss of 41 cents​.
* The mean earnings estimate of analysts had fallen by
about 33.1% in the last three months.​ 
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* Longboard Pharmaceuticals Inc shares had fallen by 0.3% this
quarter.
* The company reported a quarterly loss of $6.98 million.
* Wall Street's median 12-month price target for Longboard
Pharmaceuticals Inc is $33.50 
* The current average analyst rating on the shares is "strong
buy" and the breakdown of recommendations is 4 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 
This summary was machine generated August 9 at 01:39 p.m.  ​All
figures in US dollars unless otherwise stated